{"id":61676,"date":"2025-08-01T19:05:30","date_gmt":"2025-08-01T17:05:30","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/chemed-corporation-board-of-directors-authorizes-an-additional-300-million-for-stock-repurchase-and-declares-quarterly-dividend-of-60-cents\/"},"modified":"2025-08-01T19:05:30","modified_gmt":"2025-08-01T17:05:30","slug":"chemed-corporation-board-of-directors-authorizes-an-additional-300-million-for-stock-repurchase-and-declares-quarterly-dividend-of-60-cents","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/chemed-corporation-board-of-directors-authorizes-an-additional-300-million-for-stock-repurchase-and-declares-quarterly-dividend-of-60-cents\/","title":{"rendered":"Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents"},"content":{"rendered":"
\n

CINCINNATI–(BUSINESS WIRE)–Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed\u2019s existing share repurchase program. These shares repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility.<\/p>\n

<\/a>
<\/a><\/p>\n

\nThe Board of Directors has declared a quarterly cash dividend of 60-cents per share on the Company\u2019s capital stock, payable on August 29, 2025, to shareholders of record as of August 11, 2025. This is a 10-cent, or 20.0%, increase over the 50-cent dividend paid in June 2025. The previous increase was in August 2024, when the Board raised the quarterly dividend from 40-cents to 50-cents per share. This represents the 217th <\/sup>consecutive quarterly dividend paid by Chemed in its 54 years as a public company.<\/p>\n

\nListed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com<\/a>) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation’s largest provider of end-of-life hospice care and Roto-Rooter is the nation\u2019s leading provider of plumbing and drain cleaning services.<\/p>\n

\nStatements in this press release or in other Chemed communications may relate to future events or Chemed’s future performance. Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances. Investors are cautioned that such forward-looking statements are subject to inherent risk that actual results may differ materially from such forward-looking statements. Further, investors are cautioned that Chemed does not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations.<\/p>\n

Contacts<\/b> <\/p>\n

\nMichael D. Witzeman
\n
(513) 762-6714<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CINCINNATI–(BUSINESS WIRE)–Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed\u2019s existing share repurchase program. These shares repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility. The Board of Directors has … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61676","6":"format-standard","7":"category-industry"},"yoast_head":"\nChemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/chemed-corporation-board-of-directors-authorizes-an-additional-300-million-for-stock-repurchase-and-declares-quarterly-dividend-of-60-cents\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CINCINNATI–(BUSINESS WIRE)–Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed\u2019s existing share repurchase program. These shares repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility. The Board of Directors has ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/chemed-corporation-board-of-directors-authorizes-an-additional-300-million-for-stock-repurchase-and-declares-quarterly-dividend-of-60-cents\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-01T17:05:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250725188268\/en\/394682\/5\/Chemed_Corp_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chemed-corporation-board-of-directors-authorizes-an-additional-300-million-for-stock-repurchase-and-declares-quarterly-dividend-of-60-cents\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chemed-corporation-board-of-directors-authorizes-an-additional-300-million-for-stock-repurchase-and-declares-quarterly-dividend-of-60-cents\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents\",\"datePublished\":\"2025-08-01T17:05:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chemed-corporation-board-of-directors-authorizes-an-additional-300-million-for-stock-repurchase-and-declares-quarterly-dividend-of-60-cents\\\/\"},\"wordCount\":289,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chemed-corporation-board-of-directors-authorizes-an-additional-300-million-for-stock-repurchase-and-declares-quarterly-dividend-of-60-cents\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250725188268\\\/en\\\/394682\\\/5\\\/Chemed_Corp_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chemed-corporation-board-of-directors-authorizes-an-additional-300-million-for-stock-repurchase-and-declares-quarterly-dividend-of-60-cents\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chemed-corporation-board-of-directors-authorizes-an-additional-300-million-for-stock-repurchase-and-declares-quarterly-dividend-of-60-cents\\\/\",\"name\":\"Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chemed-corporation-board-of-directors-authorizes-an-additional-300-million-for-stock-repurchase-and-declares-quarterly-dividend-of-60-cents\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chemed-corporation-board-of-directors-authorizes-an-additional-300-million-for-stock-repurchase-and-declares-quarterly-dividend-of-60-cents\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250725188268\\\/en\\\/394682\\\/5\\\/Chemed_Corp_logo.jpg\",\"datePublished\":\"2025-08-01T17:05:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chemed-corporation-board-of-directors-authorizes-an-additional-300-million-for-stock-repurchase-and-declares-quarterly-dividend-of-60-cents\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chemed-corporation-board-of-directors-authorizes-an-additional-300-million-for-stock-repurchase-and-declares-quarterly-dividend-of-60-cents\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chemed-corporation-board-of-directors-authorizes-an-additional-300-million-for-stock-repurchase-and-declares-quarterly-dividend-of-60-cents\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250725188268\\\/en\\\/394682\\\/5\\\/Chemed_Corp_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250725188268\\\/en\\\/394682\\\/5\\\/Chemed_Corp_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/chemed-corporation-board-of-directors-authorizes-an-additional-300-million-for-stock-repurchase-and-declares-quarterly-dividend-of-60-cents\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/chemed-corporation-board-of-directors-authorizes-an-additional-300-million-for-stock-repurchase-and-declares-quarterly-dividend-of-60-cents\/","og_locale":"en_US","og_type":"article","og_title":"Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents - Pharma Trend","og_description":"CINCINNATI–(BUSINESS WIRE)–Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed\u2019s existing share repurchase program. These shares repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility. The Board of Directors has ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/chemed-corporation-board-of-directors-authorizes-an-additional-300-million-for-stock-repurchase-and-declares-quarterly-dividend-of-60-cents\/","og_site_name":"Pharma Trend","article_published_time":"2025-08-01T17:05:30+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250725188268\/en\/394682\/5\/Chemed_Corp_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/chemed-corporation-board-of-directors-authorizes-an-additional-300-million-for-stock-repurchase-and-declares-quarterly-dividend-of-60-cents\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/chemed-corporation-board-of-directors-authorizes-an-additional-300-million-for-stock-repurchase-and-declares-quarterly-dividend-of-60-cents\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents","datePublished":"2025-08-01T17:05:30+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/chemed-corporation-board-of-directors-authorizes-an-additional-300-million-for-stock-repurchase-and-declares-quarterly-dividend-of-60-cents\/"},"wordCount":289,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/chemed-corporation-board-of-directors-authorizes-an-additional-300-million-for-stock-repurchase-and-declares-quarterly-dividend-of-60-cents\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250725188268\/en\/394682\/5\/Chemed_Corp_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/chemed-corporation-board-of-directors-authorizes-an-additional-300-million-for-stock-repurchase-and-declares-quarterly-dividend-of-60-cents\/","url":"https:\/\/pharma-trend.com\/en\/chemed-corporation-board-of-directors-authorizes-an-additional-300-million-for-stock-repurchase-and-declares-quarterly-dividend-of-60-cents\/","name":"Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/chemed-corporation-board-of-directors-authorizes-an-additional-300-million-for-stock-repurchase-and-declares-quarterly-dividend-of-60-cents\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/chemed-corporation-board-of-directors-authorizes-an-additional-300-million-for-stock-repurchase-and-declares-quarterly-dividend-of-60-cents\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250725188268\/en\/394682\/5\/Chemed_Corp_logo.jpg","datePublished":"2025-08-01T17:05:30+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/chemed-corporation-board-of-directors-authorizes-an-additional-300-million-for-stock-repurchase-and-declares-quarterly-dividend-of-60-cents\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/chemed-corporation-board-of-directors-authorizes-an-additional-300-million-for-stock-repurchase-and-declares-quarterly-dividend-of-60-cents\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/chemed-corporation-board-of-directors-authorizes-an-additional-300-million-for-stock-repurchase-and-declares-quarterly-dividend-of-60-cents\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250725188268\/en\/394682\/5\/Chemed_Corp_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250725188268\/en\/394682\/5\/Chemed_Corp_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/chemed-corporation-board-of-directors-authorizes-an-additional-300-million-for-stock-repurchase-and-declares-quarterly-dividend-of-60-cents\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61676","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61676"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61676\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61676"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61676"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61676"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}